Analysis method for lipoproteins by high-performance liquid chromatography with sulfopropyl-ligand column and magnesium ion-containing eluents

被引:4
作者
Hirowatari, Y
Kurosawa, H
Yoshida, H
Doumity, K
Tada, N
机构
[1] Tosoh Corp, Sci Instruments Div, Kanagawa 2521123, Japan
[2] Jikei Univ, Sch Med, Kashiwa Hosp, Dept Clin Lab, Kashiwa, Chiba 2778567, Japan
[3] Jikei Univ, Sch Med, Kashiwa Hosp, Dept Gen Med, Kashiwa, Chiba 2778567, Japan
关键词
lipoprotein; cholesterol; chromatography;
D O I
10.1016/S0003-2697(02)00266-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have developed a new analysis method for lipoproteins in serum by high-performance liquid chromatography using a sulfopropyl-ligand column with eluents containing magnesium nitrate. The magnesium ion anchors lipoproteins to the ligands on the column gel. Lipoproteins are eluted from the column with a magnesium nitrate concentration gradient and detected by postcolumn reaction using a reagent containing cholesterol esterase and cholesterol oxidase. High-density lipoprotein, low-density lipoprotein, and very-low-density lipoprotein were eluted in order from the column. The within-assay and between-assay coefficients of variation for cholesterol concentration in lipoproteins were 1.1-3.7 and 1.3-5.8%, respectively. The correlation coefficients between the values of total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol obtained by the new method and those obtained by an enzymatic method using an automated chemical analyzer were 0.940, 0.979, and 0.909, respectively. The new method was successfully applied to the analysis of plasma lipoproteins of patients with hyperlipidemia. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:336 / 342
页数:7
相关论文
共 24 条
[1]   ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[2]  
BURSTEIN M, 1970, J LIPID RES, V11, P583
[3]  
Caslake M.J., 1997, HDB LIPOPROTEIN TEST, P509
[4]  
CHAIT A, 1993, AM J MED, V94, P347
[5]  
CHUNG BH, 1986, METHOD ENZYMOL, V128, P181
[6]  
CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36
[7]   ENHANCED SUSCEPTIBILITY TO INVITRO OXIDATION OF THE DENSE LOW-DENSITY-LIPOPROTEIN SUBFRACTION IN HEALTHY-SUBJECTS [J].
DEGRAAF, J ;
HAKLEMMERS, HLM ;
HECTORS, MPC ;
DEMACKER, PNM ;
HENDRIKS, JCM ;
STALENHOEF, AFH .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02) :298-306
[8]  
FRINGS CS, 1971, CLIN CHEM, V17, P111
[9]  
GARDNER CD, 1996, JAMA-J AM MED ASSOC, V276, P914
[10]   ROLE OF PLASMA TRIGLYCERIDE IN THE REGULATION OF PLASMA LOW-DENSITY-LIPOPROTEIN (LDL) SUBFRACTIONS - RELATIVE CONTRIBUTION OF SMALL, DENSE LDL TO CORONARY HEART-DISEASE RISK [J].
GRIFFIN, BA ;
FREEMAN, DJ ;
TAIT, GW ;
THOMSON, J ;
CASLAKE, MJ ;
PACKARD, CJ ;
SHEPHERD, J .
ATHEROSCLEROSIS, 1994, 106 (02) :241-253